Connect with us

Health

A look at COVID-19 vaccinations in Canada on Friday, Feb. 12, 2021 – Delta-Optimist

Published

 on


The latest numbers on COVID-19 vaccinations in Canada as of 10:30 p.m. ET on Friday, Feb. 12, 2021.

In Canada, the provinces are reporting 35,449 new vaccinations administered for a total of 1,221,539 doses given. The provinces have administered doses at a rate of 3,223.12 per 100,000.

There were 3,510 new vaccines delivered to the provinces and territories for a total of 1,313,225 doses delivered so far. The provinces and territories have used 93.02 per cent of their available vaccine supply.

Please note that Newfoundland, P.E.I., Nova Scotia, New Brunswick and the territories typically do not report on a daily basis.

Newfoundland is reporting 2,091 new vaccinations administered over the past seven days for a total of 14,687 doses given. The province has administered doses at a rate of 28.048 per 1,000. There were zero new vaccines delivered to Newfoundland for a total of 19,975 doses delivered so far. The province has received enough of the vaccine to give 3.8 per cent of its population a single dose. The province has used 73.53 per cent of its available vaccine supply.

P.E.I. is reporting 802 new vaccinations administered over the past seven days for a total of 9,139 doses given. The province has administered doses at a rate of 57.612 per 1,000. There were zero new vaccines delivered to P.E.I. for a total of 10,200 doses delivered so far. The province has received enough of the vaccine to give 6.4 per cent of its population a single dose. The province has used 89.6 per cent of its available vaccine supply.

Nova Scotia is reporting 5,048 new vaccinations administered over the past seven days for a total of 22,343 doses given. The province has administered doses at a rate of 22.895 per 1,000. There were zero new vaccines delivered to Nova Scotia for a total of 34,800 doses delivered so far. The province has received enough of the vaccine to give 3.6 per cent of its population a single dose. The province has used 64.2 per cent of its available vaccine supply.

New Brunswick is reporting 1,366 new vaccinations administered over the past seven days for a total of 18,643 doses given. The province has administered doses at a rate of 23.90 per 1,000. There were zero new vaccines delivered to New Brunswick for a total of 25,850 doses delivered so far. The province has received enough of the vaccine to give 3.3 per cent of its population a single dose. The province has used 72.12 per cent of its available vaccine supply.

Quebec is reporting 8,280 new vaccinations administered for a total of 280,612 doses given. The province has administered doses at a rate of 32.795 per 1,000. There were zero new vaccines delivered to Quebec for a total of 310,425 doses delivered so far. The province has received enough of the vaccine to give 3.6 per cent of its population a single dose. The province has used 90.4 per cent of its available vaccine supply.

Ontario is reporting 15,605 new vaccinations administered for a total of 442,441 doses given. The province has administered doses at a rate of 30.12 per 1,000. There were zero new vaccines delivered to Ontario for a total of 437,975 doses delivered so far. The province has received enough of the vaccine to give 3.0 per cent of its population a single dose. The province has used 101 per cent of its available vaccine supply.

Manitoba is reporting 1,408 new vaccinations administered for a total of 52,664 doses given. The province has administered doses at a rate of 38.245 per 1,000. There were 3,510 new vaccines delivered to Manitoba for a total of 69,600 doses delivered so far. The province has received enough of the vaccine to give 5.1 per cent of its population a single dose. The province has used 75.67 per cent of its available vaccine supply.

Saskatchewan is reporting 525 new vaccinations administered for a total of 46,788 doses given. The province has administered doses at a rate of 39.679 per 1,000. There were zero new vaccines delivered to Saskatchewan for a total of 44,575 doses delivered so far. The province has received enough of the vaccine to give 3.8 per cent of its population a single dose. The province has used 105 per cent of its available vaccine supply.

Alberta is reporting 4,814 new vaccinations administered for a total of 140,389 doses given. The province has administered doses at a rate of 31.892 per 1,000. There were zero new vaccines delivered to Alberta for a total of 132,475 doses delivered so far. The province has received enough of the vaccine to give 3.0 per cent of its population a single dose. The province has used 106 per cent of its available vaccine supply.

British Columbia is reporting 3,095 new vaccinations administered for a total of 162,982 doses given. The province has administered doses at a rate of 31.761 per 1,000. There were zero new vaccines delivered to British Columbia for a total of 186,550 doses delivered so far. The province has received enough of the vaccine to give 3.6 per cent of its population a single dose. The province has used 87.37 per cent of its available vaccine supply.

Yukon is reporting 80 new vaccinations administered for a total of 11,514 doses given. The territory has administered doses at a rate of 275.91 per 1,000. There were zero new vaccines delivered to Yukon for a total of 14,400 doses delivered so far. The territory has received enough of the vaccine to give 35 per cent of its population a single dose. The territory has used 79.96 per cent of its available vaccine supply.

The Northwest Territories are reporting zero new vaccinations administered for a total of 13,132 doses given. The territory has administered doses at a rate of 291.053 per 1,000. There were zero new vaccines delivered to the Northwest Territories for a total of 14,400 doses delivered so far. The territory has received enough of the vaccine to give 32 per cent of its population a single dose. The territory has used 91.19 per cent of its available vaccine supply.

Nunavut is reporting 20 new vaccinations administered for a total of 6,205 doses given. The territory has administered doses at a rate of 160.228 per 1,000. There were zero new vaccines delivered to Nunavut for a total of 12,000 doses delivered so far. The territory has received enough of the vaccine to give 31 per cent of its population a single dose. The territory has used 51.71 per cent of its available vaccine supply.

*Notes on data: The figures are compiled by the COVID-19 Open Data Working Group based on the latest publicly available data and are subject to change. Note that some provinces report weekly, while others report same-day or figures from the previous day. Vaccine doses administered is not equivalent to the number of people inoculated as the approved vaccines require two doses per person. The vaccines are currently not being administered to children under 18 and those with certain health conditions. In some cases the number of doses administered may appear to exceed the number of doses distributed as some provinces have been drawing extra doses per vial.

This report was automatically generated by The Canadian Press Digital Data Desk and was first published Feb. 12, 2021.

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Federal panel recommends 4-month gap between COVID vaccine doses due to limited supply – Terrace Standard – Terrace Standard

Published

 on


The National Advisory Committee on Immunization (NACI) is supporting B.C.’s decision to delay the second doses of COVID-19 vaccines by up to four months.

“NACI recommends that in the context of limited COVID-19 vaccine supply jurisdictions should maximize the number of individuals benefiting from the first dose of vaccine by extending the second dose of COVID-19 vaccine up to four months after the first,” the committee said in a decision published Wednesday (March 3).

The recommendation applies to all COVID-19 vaccines currently approved in Canada; Pfizer-BioNTech, Moderna and the newly approved AstroZeneca vaccine.

B.C. announced the decision to delay the second booster shot for four months on Monday, which health officials said could mean that all adults in the province could have their first dose by July.

READ MORE: Most B.C. adults could get their first COVID vaccine shot by July: health officials

Both provincial health officer Dr. Bonnie Henry and NACI said that its rationale was based on both the current available vaccine supply and data from other countries.

A study published by the University of Cambridge in the U.K., which has not yet been peer-reviewed, suggests that a single dose of the Pfizer-BioNTech vaccine can reduce the number of asymptomatic COVID-19 infections by 75 per cent.

In Israel, researchers studied the effects of a single dose of the same vaccine and published their findings in The Lancet medical journal, concluding that it was 85 per cent effective against symptomatic COVID-19 infections.

Also in The Lancet, a U.K. study found that the Oxford-AstraZeneca vaccine is 81 per cent effective when its second dose is given three months after the first, compared with 55 per cent efficacy after six weeks.

The national advisory committee noted that since the COVID-19 vaccines are still new, its unknown how long the protection of one or both doses lasts for.

“Experience with other multi-dose vaccines after a single dose suggests persistent protection could last for six months or longer in adolescents and adults,” NACI said in its statement. “Longer-term follow-up of clinical trial participants and those receiving vaccination in public programs will assist in determining the duration of protection following both one and two doses of vaccination.”

The national advisory committee added that it’s unknown how a delayed booster shot regime will affect the spread of variants of concern, including the U.K. and South African ones. However, NACI notes that there is “currently no evidence that an extended interval between doses will either increase or decrease the emergence of variants of concern.”

The committee noted that all three currently approved vaccines have shown “promising early result” against the U.K. variant B.1.1.7.

READ MORE: COVID-19 wage and rent subsidies, lockdown support to be extended until June

– with files from The Canadian Press


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada vaccine panel recommends 4 months between COVID doses – ABC News

Published

 on


TORONTO — A national panel of vaccine experts in Canada recommended Wednesday that provinces extend the interval between the two doses of a COVID-19 shot to four months to quickly inoculate more people amid a shortage of doses in Canada.

A number of provinces said they would do just that.

Second doses would begin to be administered in July as more shipments arrive, the panel said, noting that 55 million doses are expected to be delivered in July, August and September.

In comparison, the federal government previously said 38% of people would receive two doses by the end of June.

“They are making, I think, a reasonable calculation in a time of drug shortage,” said Dr. Andrew Morris, a professor of infectious diseases at the University of Toronto and the medical director of the Antimicrobial Stewardship Program at Sinai-University Health Network. “It’s the right decision in my mind. Let me ask … A couple are given two vaccines. Do you give two to one, or give one each one dose? It’s a no brainer.”

The addition of the newly approved AstraZeneca vaccine to the country’s supply could mean almost all Canadians would get their first shot in that time frame.

“The vaccine effectiveness of the first dose will be monitored closely and the decision to delay the second dose will be continuously assessed based on surveillance and effectiveness data and post-implementation study designs,” the panel wrote.

“Effectiveness against variants of concern will also be monitored closely, and recommendations may need to be revised,” it said, adding there is currently no evidence that a longer interval will affect the emergence of the variants.

The updated guidance applies to all three of the vaccines currently approved for use in Canada.

Manitoba and Quebec also said Wednesday they will delay second doses. And Ontario’s health minister said it would Ontario to rapidly accelerate its vaccine rollout.

Earlier Wednesday, Trudeau said any change in public health guidance regarding the timing of the two doses could affect the speed of Canada’s vaccine rollout, as could the approval of more vaccines like Johnson and Johnson.

Canada’s provinces administer health care in the country so it’s ultimately up to the provinces.

Dr. Brad Wouters, executive vice-president of science and research at University Health Network, cast doubt on the recommendation. “Nobody in the world has been 4 months between doses. These are RNA vaccines never used before. We should use evidence to make decisions. Canada conducting a population experiment,” Wouters tweeted.

And Mona Nemer, the federal government’s Chief Science Advisor, also said this week that the plan amounts to a “population-level experiment” and that the data provided so far by Moderna and Pfizer-BioNTech is based on an interval of three to four weeks between doses.

But Dr. Bonnie Henry, British Columbia’s provincial health officer, said the manufacturers structured their clinical trials that way to get the vaccines to market as quickly as possible, but said research in British Columbia, Quebec, Israel and the United Kingdom has shown that first doses are highly effective.

Dr. Supriya Sharma, chief medical adviser for Health Canada, the country’s regulator, told the Canadian Broadcasting Corporation in a time of limited supply they are starting to have greater comfort with the idea of waiting for the second dose after seeing real world data versus the strict interpretation of the clinical trials.

“In the real world we’re starting to see evidence from other countries that have delayed that second dose ‘Oh, it looks like they still have a really good effectiveness.’ We have lab studies that show it’s unlikely that immune response will drop off,” Sharma said.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Federal panel recommends 4-month gap between COVID vaccine doses due to limited supply – Maple Ridge News – Maple Ridge News

Published

 on


The National Advisory Committee on Immunization (NACI) is supporting B.C.’s decision to delay the second doses of COVID-19 vaccines by up to four months.

“NACI recommends that in the context of limited COVID-19 vaccine supply jurisdictions should maximize the number of individuals benefiting from the first dose of vaccine by extending the second dose of COVID-19 vaccine up to four months after the first,” the committee said in a decision published Wednesday (March 3).

The recommendation applies to all COVID-19 vaccines currently approved in Canada; Pfizer-BioNTech, Moderna and the newly approved AstroZeneca vaccine.

B.C. announced the decision to delay the second booster shot for four months on Monday, which health officials said could mean that all adults in the province could have their first dose by July.

READ MORE: Most B.C. adults could get their first COVID vaccine shot by July: health officials

Both provincial health officer Dr. Bonnie Henry and NACI said that its rationale was based on both the current available vaccine supply and data from other countries.

A study published by the University of Cambridge in the U.K., which has not yet been peer-reviewed, suggests that a single dose of the Pfizer-BioNTech vaccine can reduce the number of asymptomatic COVID-19 infections by 75 per cent.

In Israel, researchers studied the effects of a single dose of the same vaccine and published their findings in The Lancet medical journal, concluding that it was 85 per cent effective against symptomatic COVID-19 infections.

Also in The Lancet, a U.K. study found that the Oxford-AstraZeneca vaccine is 81 per cent effective when its second dose is given three months after the first, compared with 55 per cent efficacy after six weeks.

The national advisory committee noted that since the COVID-19 vaccines are still new, its unknown how long the protection of one or both doses lasts for.

“Experience with other multi-dose vaccines after a single dose suggests persistent protection could last for six months or longer in adolescents and adults,” NACI said in its statement. “Longer-term follow-up of clinical trial participants and those receiving vaccination in public programs will assist in determining the duration of protection following both one and two doses of vaccination.”

The national advisory committee added that it’s unknown how a delayed booster shot regime will affect the spread of variants of concern, including the U.K. and South African ones. However, NACI notes that there is “currently no evidence that an extended interval between doses will either increase or decrease the emergence of variants of concern.”

The committee noted that all three currently approved vaccines have shown “promising early result” against the U.K. variant B.1.1.7.

READ MORE: COVID-19 wage and rent subsidies, lockdown support to be extended until June

– with files from The Canadian Press


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Trending